296 results
Page 4 of 15
8-K
EX-99.1
4e7xxx96r2y eg9ux
9 May 19
Dynavax Announces First Quarter 2019 Financial Results
4:05pm
8-K
EX-99.1
rprrmai
18 Mar 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:10pm
8-K
EX-99.1
dfwnvo
27 Feb 19
Dynavax Announces Fourth Quarter 2018 and Full Year 2018 Financial Results
12:00am
8-K
EX-99.1
ctk j8orlynl
6 Nov 18
Dynavax Reports Third Quarter 2018 Financial Results, Progress on HEPLISAV-B Launch, and Updated SD-101 Data in Three Patient Populations
4:05pm
8-K
EX-99.2
av1e8 n7mqlr4
22 Oct 18
Other Events
9:01am
8-K
EX-99.1
uj58b9zzcln
22 Oct 18
Other Events
9:01am
8-K
EX-99.1
rt1cy31drxr7j 3box
7 Aug 18
Dynavax Reports Second Quarter 2018 Financial Results
12:00am
8-K
EX-99.3
7rhifb2hj
5 Jun 18
Other Events
12:00am
8-K
EX-99.1
y9uxma2jnmrxcz60g
5 Jun 18
Other Events
12:00am
8-K
EX-99.2
uylt5bnutd223w
5 Jun 18
Other Events
12:00am
8-K
EX-99.1
u37gmi74ch16l6lv0pym
9 May 18
Dynavax Reports First Quarter 2018 Financial Results
4:10pm
8-K
EX-99.1
56umvq8xugh
26 Apr 18
Dynavax’s HEPLISAV-B® ACIP Recommendations Published in the CDC’s Morbidity and Mortality Weekly Report
4:10pm